Collins W E, Sullivan J S, Fryauff D J, Kendall J, Jennings V, Galland G G, Morris C L
National Center for Infectious Diseases, Centers for Disease Control and Prevention, United States Department of Health and Human Services, Atlanta, Georgia 30333, USA.
Am J Trop Med Hyg. 2000 Apr;62(4):491-5. doi: 10.4269/ajtmh.2000.62.491.
The spread of chloroquine-resistant Plasmodium vivax from Papua New Guinea and Indonesia poses a serious health threat to areas of Southeast Asia where this species of malaria parasite is endemic. A strain of P. vivax from Indonesia was adapted to develop in splenectomized Aotus lemurinus griseimembra, Aotus vociferans, Aotus nancymai, and Saimiri boliviensis monkeys. Transmission to splenectomized Saimiri monkeys was obtained via sporozoites. Chemotherapeutic studies indicated that the strain was resistant to chloroquine and amodiaquine while sensitive to mefloquine. Infections of chloroquine-resistant P.vivax in New World monkeys should be useful for the development of alternative treatments.
来自巴布亚新几内亚和印度尼西亚的氯喹抗性间日疟原虫的传播,对东南亚该种疟疾寄生虫为地方流行的地区构成了严重的健康威胁。一株来自印度尼西亚的间日疟原虫适应于在脾切除的灰手夜猴、叫夜猴、南氏夜猴和玻利维亚松鼠猴体内发育。通过子孢子实现了向脾切除的松鼠猴的传播。化疗研究表明,该菌株对氯喹和阿莫地喹耐药,而对甲氟喹敏感。新大陆猴体内氯喹抗性间日疟原虫的感染对于开发替代治疗方法应是有用的。